Raziel Therapeutics
PrivateLast Round
Strategic
Jun 28, 2026
Total Funding Raised
$27.1M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Raziel Therapeutics is a clinical-stage pharmaceutical company developing a proprietary injectable compound for non-surgical, targeted fat reduction.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Medical Devices, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Raziel Therapeutics Comparables
Compare Raziel Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Caliway Biopharmaceuticals | 87% | |
| AMI Pharm Co., Ltd. | 83% | |
| Marllor Biomedical | 81% |
Raziel Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Strategic | Jun 28, 2026 | ||||
| Strategic | Oct 30, 2025 | ||||
| Series C | Dec 18, 2019 | ||||
| Series A | Feb 1, 2016 | ||||
| Seed | Dec 1, 2014 |
Raziel Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Israel Innovation Authority | Seed |
| Pontifax Venture Capital | Series A, Series C |
| Docor International Management | Series A, Series C |
| Catalyst Investments Group | Series C |
| Wille Finance AG | Series C |
| Peregrine Ventures | Strategic, Series C |
| VLX Ventures | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 28, 2026
Raised a strategic round with GC Wellbeing as an investor.
- Oct 30, 2025
Raised capital from Peregrine Ventures and 365mc.
Raziel Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Raziel Therapeutics's valuation, stock price, and market status.
Is Raziel Therapeutics a public or private company?
Raziel Therapeutics is a private company.
What is the current stock price of Raziel Therapeutics?
Raziel Therapeutics is a private company with no public stock price. Caplight tracks Raziel Therapeutics's secondary market activity and provides MarketPrice™ estimates to Caplight users.
How much is Raziel Therapeutics worth (valuation)?
Valuation information for Raziel Therapeutics is not publicly available.
Can I buy Raziel Therapeutics stock?
Raziel Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Raziel Therapeutics's last funding round?
Raziel Therapeutics's most recent funding round was Strategic on June 28, 2026.
Who are the main investors in Raziel Therapeutics?
Key investors in Raziel Therapeutics include Pontifax Venture Capital.
Will Raziel Therapeutics IPO soon?
No public IPO plans have been announced for Raziel Therapeutics.
How can I track Raziel Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Raziel Therapeutics's secondary market activity and sign up for updates.